跳至主要内容
临床试验/NCT05631405
NCT05631405招募中不适用

Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone

Chulalongkorn University2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年10月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
2
主要终点
Mortality

研究概览

简要总结

The goal of this randomized double-blinded placebo-controlled trial is to learn about dexamethasone and the treatment of severe dengue population. The main question it aims to answer are steroid therapy may be effective in dengue.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
7 Years 至 99 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Laboratory confirmed Dengue infected patients (Positive NS1 Ag or anti-DENV IgM by Dengue Duo test)
  • And still in febrile phase (Body temp>37.5 C)
  • Shock : Sys<90mmHg or Narrow PP (<20mmHg) orTachycardia (pulse>100/min) with Hematocrit decreased ≥20 %
  • Fluid accumulation and respiratory distress
  • Severe bleeding
  • Severe organ involvement

排除标准

  • Severe dengue> 24 hrs
  • Dengue without warning signs
  • Pregnancy
  • Patient who receieved any steroid within 1 week

研究组 & 干预措施

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

Intervention

Experimental

干预措施: Dexamethasone (Drug)

结局指标

主要结局

Mortality

时间窗: 28 days

The use of steroids in dengue will reduce mortality in rate

次要结局

  • Length of hospital stay(28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nattachai Srisawat ,M.D.

Principal investigator

Chulalongkorn University

研究点 (2)

Loading locations...

相似试验